CAPTRUST Financial Advisors
TMCI icon

CAPTRUST Financial Advisors’s Treace Medical Concepts TMCI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99K Buy
+500
New +$1.37K ﹤0.01% 3267

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CAPTRUST Financial Advisors's TMCI Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Treace Medical Concepts (TMCI) stake by 81% in Q2 2026, buying an estimated $64.3K and bringing the position to 52,265 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

CAPTRUST Financial Advisors first reported a position in TMCI in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.4M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • CAPTRUST Financial Advisors held 52,265 shares of Treace Medical Concepts worth $208K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 23,378 Treace Medical Concepts shares in Q2 2026, an estimated $64.3K.
  • Treace Medical Concepts made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2854 holding.
  • CAPTRUST Financial Advisors first reported a position in Treace Medical Concepts in Q4 2021 and has held it in 10 quarters since.
  • CAPTRUST Financial Advisors's Treace Medical Concepts position peaked at $1.4M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.